diagnosis Archives -

Digital health startup Oncoustics has raised $5.5 million in seed funding to develop an artificial intelligence-powered technology that

Oncoustics raises $5.5m for ‘virtual biopsy’ AI platform

https://pharmaphorum.com/news/oncoustics-raises-5-5m-for-virtual-biopsy-ai-platform/

Digital/ News/ News

Alimetry nabs FDA okay for gastric disorder-diagnosing wearable

Phil Taylor Alimetry, diagnosis, digital, digital health, Gastric Alimetry, gastrointestinal, wearable 0 Comment

New Zealand medical tech startup Alimetry has claimed an FDA approval for a wearable device that can be

Alimetry nabs FDA okay for gastric disorder-diagnosing wearable

https://pharmaphorum.com/news/alimetry-nabs-fda-okay-for-gastric-disorder-diagnosing-wearable/

Digital/ News/ News/ News/ Patients

Could an eye test spot people at risk of heart attacks?

Phil Taylor cardiovascular disease, diagnosis, digital health, ophthalmology 0 Comment

An analysis of images of the retina harvested from the UK Biobank resource suggests that it may be

Could an eye test spot people at risk of heart attacks?

https://pharmaphorum.com/news/could-an-eye-test-spot-people-at-risk-of-heart-attacks/

Market Access/ News/ News/ News/ Oncology

Angle claims FDA okay for Parsortix liquid biopsy system

Phil Taylor Angle, breast cancer, diagnosis, liquid biopsy, Oncology, Parsortix, regulatory approval 0 Comment

After more than six years of development, Angle has scored an FDA approval for Parsortix as a diagnostic

Angle claims FDA okay for Parsortix liquid biopsy system

https://pharmaphorum.com/news/angle-claims-fda-okay-for-parsortix-liquid-biopsy-system/

Market Access/ News/ News/ News/ Patients

FDA approves first in vitro test for early Alzheimer’s disease

Phil Taylor Alzheimer's disease, diagnosis, in vitro, neurology, regulatory approval 0 Comment

The US FDA has authorised a new test that can detect amyloid plaques in early-stage Alzheimer’s disease without

FDA approves first in vitro test for early Alzheimer’s disease

https://pharmaphorum.com/news/fda-approves-first-in-vitro-test-for-early-alzheimers-disease/

Digital/ News/ News/ News/ Oncology

Smartphone-based skin cancer diagnostic certified for use in UK

Phil Taylor Artifical Intellgence, DERM, diagnosis, digital, digital health, Oncology, Skin Analytics 0 Comment

An artificial intelligence-powered digital tool for diagnosing skin cancers developed by Skin Analytics has been cleared in the

Smartphone-based skin cancer diagnostic certified for use in UK

https://pharmaphorum.com/news/smartphone-based-skin-cancer-diagnostic-certified-for-use-in-uk/

News/ News/ Patients

UK government ‘not doing enough on early cancer diagnosis’

Phil Taylor diagnosis, NHS, NHS England, Oncology, patients 0 Comment

Parliamentarians in the UK have warned that the government is not making the effort needed to reach its

UK government ‘not doing enough on early cancer diagnosis’

https://pharmaphorum.com/news/uk-government-not-doing-enough-on-early-cancer-diagnosis/

News/ News/ Patients

Illumina debuts its multi-gene test for cancer in Europe

Phil Taylor diagnosis, genome, Illumina, Oncology, rare disease, TruSight Oncology 0 Comment

Gene sequencing specialist Illumina has started rolling out a new test that looks for a battery of tumour-associated

Illumina debuts its multi-gene test for cancer in Europe

https://pharmaphorum.com/news/illumina-debuts-multi-gene-test-for-cancer-in-europe/

News/ News/ Patients

As England ends free COVID testing, company debuts £1.99 LFT

Phil Taylor coronavirus, COVID-19, COVID-19 detection kits, diagnosis, Everything Genetic 0 Comment

From 1 April, it will be no longer be possible for most people in England to get access

As England ends free COVID testing, company debuts £1.99 LFT

https://pharmaphorum.com/news/as-england-ends-free-covid-testing-company-debuts-1-99-lft/

Trending

diagnosis

Login